Clinical Trial: IASO206 in Patients With Relapsed/Refractory Autoimmune Hemolytic Anemia

U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT07585071) titled 'IASO206 in Patients With Relapsed/Refractory Autoimmune Hemolytic Anemia' on May 06.

Brief Summary: This study is an open-label, single-arm early exploratory clinical study, aiming to evaluate the safety, tolerability and preliminary efficacy of IASO206 Injection (In Vivo CAR-T) in Patients with Relapsed/Refractory Autoimmune Hemolytic Anemia

Study Start Date: June 15

Study Type: INTERVENTIONAL

Condition: Autoimmune Hemolytic Anemia Relapsed/Refractory

Intervention: BIOLOGICAL: IASO206 injection

The third-generation self-inactivating lentiviral vector that carries a BCMA-targeted CAR. Administered in one infusion.

Recruitment...